SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NPSP NPS Pharmaceutical
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (329)1/31/2011 1:58:24 PM
From: tuck  Read Replies (1) of 363
 
With today's news of GATTEX meeting primary endpoints, the stock has hit a multiyear high, and a financing seems inevitable.

npsp.com

But that was, after all, the best case scenario. OK the results were slightly behind schedule, but no biggie, except that that makes the financing even more likely. But it should be a well received financing that doesn't pressure the stock much or for long, as it will be funding a launch in a year or so.

This has been in my Mom's portfolio in some size for years. We've suffered through the PREOS disaster. This is a case where buy and hold can make sense: when the company has pipeline. Contrast with Arena, from which we bailed. Holding NPSP still.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News